At a glance
ClinicalIndex Comparison RecordN/ACompleted· 144 enrolled
Drug / intervention
Chordate System S211 in treatment mode +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine
In Brief
A clinical study evaluating Chordate System S211 in treatment mode and Chordate System S211 in placebo mode for Chronic Migraine. Completed, enrolled 144 participants across 10 sites in 2 countries.
Detailed Summary
The efficacy of intranasal kinetic oscillation stimulation using the Chordate System S211 as a preventative treatment will be examined in patients diagnosed with chronic migraine. The medical device system will be applied in 6 treatments at weekly intervals. The study will examine the effects on monthly headache days with moderate to severe intensity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Migraine
CountriesFinland, Germany
CollaboratorsVinnova, FGK Clinical Research GmbH
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 2018
Enrollment StartMar 2018
Primary CompletionAug 2022
TodayJul 2026
First PostedJan 17, 2018
Enrollment StartMar 22, 2018
Primary CompletionAug 1, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 8.5 years ago
Interventions
Chordate System S211 in treatment modedevice
Chordate System S211 in treatment mode
Chordate System S211 in placebo modedevice
Chordate System S211 in placebo mode